- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration-sensitive Prostate Cancer
Total 10883 results
-
Rahul AggarwalSanofiCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Cellular Biomedicine Group Ltd.Fudan UniversityUnknownMetastatic Castration-resistant Prostate CancerChina
-
Jeffrey Yachnin M.D., PhD.SanofiCompletedMetastatic Castration Resistant Prostate CancerSweden
-
Astellas Pharma Global Development, Inc.Medivation, Inc.WithdrawnMetastatic Castration-Resistant Prostate Cancer
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
British Columbia Cancer AgencyRecruitingProstate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate CancerCanada
-
Shanghai Changzheng HospitalBioray LaboratoriesRecruitingCastration-resistant Prostate Cancer | Metastatic Castration-resistant Prostate CancerChina
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
National Cancer Institute (NCI)TerminatedProstate Neoplasms | Metastatic Castration Resistant Prostate CancerUnited States
-
Astellas Pharma Korea, Inc.Not yet recruitingMetastatic Hormone-Sensitive Prostate Cancer
-
Jianbin BiNot yet recruitingMetastatic Hormone-Sensitive Prostate Cancer
-
BayerRecruitingMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Japan
-
Janssen-Cilag Ltd.RecruitingMetastatic Hormone-sensitive Prostate CancerFrance, Germany, Spain, Greece, United Kingdom, Austria
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)Not yet recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer
-
Dana-Farber Cancer InstituteNovartisRecruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University of California, San FranciscoConquer Cancer FoundationCompletedProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Epizyme, Inc.; PfizerActive, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
Athenex, Inc.CompletedBone-Metastatic, Castration-Resistant Prostate CancerUnited States
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Progressive Castration-resistant Prostate CancerUnited States
-
Duke UniversityBayerCompletedPharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate CancerBone Metastatic Castration-Resistant Prostate CancerUnited States
-
Avionco LLCCompletedMetastatic Castration-Resistant Prostate Cancer (mCRPC)Russian Federation
-
UNC Lineberger Comprehensive Cancer CenterWithdrawnMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedMetastatic Castration Resistant Prostate Cancer PatientsFrance
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.CompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Tiltan Pharma Ltd.UnknownMetastatic Castration Resistant Prostate Cancer (CRPC)Israel
-
Tianjin Medical University Second HospitalThe Second Hospital of Hebei Medical University; Tianjin Medical University... and other collaboratorsCompleted
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)UnknownCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
BayerActive, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)China
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...European Institute of Oncology; ASST Santi Paolo e CarloRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)Italy
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZenecaActive, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer | Prostate Cancer Metastatic Castration-Resistant | Abnormal DNA RepairUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...WithdrawnProstate Cancer | Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)United States
-
BayerCompletedBone Metastatic Castration-resistant Prostate CancerGermany, Netherlands, Denmark